The Department of Cardiovascular Medicine at Shanghai East Hospital, Tongji University School of Medicine, is a national key clinical specialty anchored by the National Key Laboratory of Heart Disease. Founded within a hospital established in 1920 in Pudong, the department is led by Chinese Academy of Sciences Academician Chen Yihan and delivers near-complete coverage of cardiovascular care, from complex arrhythmia ablation to artificial heart implantation.
Academic Platforms
National Key Laboratory of Heart Disease
Directed by Academician Chen Yihan, with an NSFC Basic Science Center for Heart Disease and a National Science Fund for Creative Research Groups.
National Key Clinical Specialty
Backed by a National Innovation and Talent-Introduction Base and a collaborative base of the National Cardiovascular Clinical Research Center.
Three NHC Training Bases
National interventional training bases of the National Health Commission covering coronary heart disease, structural heart disease and arrhythmia.
Municipal Leadership
Shanghai Top Priority Arrhythmia Research Center, Shanghai Municipal Education Commission key discipline in heart disease, and Pudong New District Peak Discipline.
Scale & Equipment
208 Beds
Eight general cardiology wards and two cardiovascular intensive care units.
12 Catheterization Labs
Including two hybrid operating rooms with 12 DSA systems; Asia's first intelligently customized hybrid OR integrates MRI, CT, DSA, ultrasound and a surgical table for one-stop treatment.
High Annual Volume
More than 12,000 procedures and nearly 300,000 outpatient visits per year, with advanced tools such as Pheno-DSA, Carto/EnSite 3D mapping, IVUS/OCT/FFR/QFR, shockwave, ELCA and Rota systems, plus IABP and ECMO support.
Core Strengths
Arrhythmia & Heart Failure
Academician Chen Yihan's clinical focus; he was the first in the world to discover a human atrial fibrillation-causing gene, published in Science.
High-Risk Complex Coronary Intervention (CHIP)
Led by Prof. Zhang Qi's Coronary Heart Disease Diagnosis and Treatment Center; annual coronary intervention volume ranked among the top three in Shanghai per a 2019 report.
Structural Heart Disease
TAVR, mitral TEER, left atrial appendage closure and interventional treatment of congenital heart disease.
End-Stage Heart Failure
Prof. Liu Zhongmin's team performs artificial heart implantation and heart-lung transplantation, and developed China's first human umbilical cord mesenchymal stem cell injection for heart failure, now in Phase I trials.
International Services
Agreements with 60+ overseas insurers, the only designated hospital in China for French national health insurance, and the world's first WHO-certified international emergency medical team.
Conditions Treated
Expert Team
Prof. Chen Yihan
Academician of the Chinese Academy of Sciences; Vice President of Tongji University, President of Shanghai East Hospital and Director of the National Key Laboratory of Heart Disease; first to discover a human AF-causing gene (Science).
Prof. Liu Zhongmin
Foreign academician of the Russian Academy of Engineering and Lifetime Professor; expert in artificial heart implantation and heart-lung transplantation for end-stage heart failure.
Prof. Zhang Qi
Executive Deputy Director of Cardiology and Director of the Coronary Heart Disease Diagnosis and Treatment Center; specializes in high-risk complex coronary intervention (CHIP).
Campuses & Contact
Lujiazui Campus (Main)
5th Floor, Department of Cardiology, No. 150 Jimo Road, Pudong New District, Shanghai; phone 021-38804518-17213.
Qiantan Campus (South)
No. 1800 Yuntai Road, Pudong New District, Shanghai.
International Patients
30,000+ international patient visits per year; website https://www.easthospital.cn.